Published in Hepatitis Weekly, November 23rd, 1998
Patients who have been exposed to the hepatitis B virus (HBV) and who were able to clear the hepatitis B surface antigen from the serum and to develop anti-hepatitis B surface antigen (anti-HBs) antibodies have not previously been considered at risk for HBV reactivation after solid organ transplantation.
In this report, researcher C. Blanpain et al. observed three solid organ transplant recipients who demonstrated clinically significant HBV reactivation after transplantation.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly